• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌-睾丸抗原PRAME的免疫组织化学检测

Immunohistochemical Detection of Cancer-Testis Antigen PRAME.

作者信息

Lezcano Cecilia, Müller Annette M, Frosina Denise, Hernandez Enmily, Geronimo Jerica A, Busam Klaus J, Jungbluth Achim A

机构信息

5803Memorial Sloan-Kettering Cancer Center, New York, USA.

27182University Hospital of Cologne, Cologne, Germany.

出版信息

Int J Surg Pathol. 2021 Dec;29(8):826-835. doi: 10.1177/10668969211012085. Epub 2021 Apr 23.

DOI:10.1177/10668969211012085
PMID:33890816
Abstract

Cancer-testis (CT) antigens were identified by their ability to elicit T- or B-cell immune responses in the autologous host. They are typically expressed in a wide variety of neoplasms and in normal adult tissues are restricted to testicular germ cells. PReferentially expressed Antigen of Melanoma (PRAME) is a member of the family of nonclassical CT antigens being expressed in a few other normal tissues besides testis. Interestingly, knowledge about the protein expression of many CT antigens is still incomplete due to the limited availability of reagents for their immunohistochemical detection. Here, we tested several commercially available serological reagents and identified a monoclonal antibody suitable for the immunohistochemical detection of PRAME in formalin-fixed paraffin-embedded specimens. We also tested a wide array of normal and neoplastic tissues. PRAME protein expression in normal tissues is congruent with original molecular data being present in the testis, and at low levels in the endometrium, adrenal cortex, and adult as well as fetal ovary. In tumors, there is diffuse PRAME immunoreactivity in most metastatic melanomas, myxoid liposarcomas, and synovial sarcomas. Other neoplasms such as seminomas and carcinomas of various origins including endometrial, serous ovarian, mammary ductal, lung, and renal showed an intermediate proportion of cases and variable extent of tumor cells positive for PRAME protein expression. As seen with other CT antigens, hepatocellular and colorectal carcinoma, Leydig cell tumors, mesothelioma, and leiomyosarcoma are poor expressers of PRAME.

摘要

癌-睾丸(CT)抗原是根据其在自体宿主中引发T细胞或B细胞免疫反应的能力而确定的。它们通常在多种肿瘤中表达,而在正常成人组织中则仅限于睾丸生殖细胞。黑色素瘤优先表达抗原(PRAME)是非经典CT抗原家族的成员,除睾丸外还在其他一些正常组织中表达。有趣的是,由于用于免疫组织化学检测的试剂有限,许多CT抗原的蛋白质表达情况仍不完整。在此,我们测试了几种市售血清学试剂,并鉴定出一种适用于在福尔马林固定石蜡包埋标本中免疫组织化学检测PRAME的单克隆抗体。我们还测试了多种正常组织和肿瘤组织。PRAME在正常组织中的蛋白表达与睾丸中原始分子数据一致,在子宫内膜、肾上腺皮质、成年及胎儿卵巢中表达水平较低。在肿瘤中,大多数转移性黑色素瘤、黏液样脂肪肉瘤和滑膜肉瘤中存在弥漫性PRAME免疫反应性。其他肿瘤,如精原细胞瘤和各种起源的癌,包括子宫内膜癌、浆液性卵巢癌、乳腺导管癌、肺癌和肾癌,PRAME蛋白表达呈阳性的病例比例中等,肿瘤细胞阳性程度各异。与其他CT抗原一样,肝细胞癌、结直肠癌、睾丸间质细胞瘤、间皮瘤和平滑肌肉瘤是PRAME的低表达者。

相似文献

1
Immunohistochemical Detection of Cancer-Testis Antigen PRAME.癌-睾丸抗原PRAME的免疫组织化学检测
Int J Surg Pathol. 2021 Dec;29(8):826-835. doi: 10.1177/10668969211012085. Epub 2021 Apr 23.
2
PRAME Expression in Cancer. A Systematic Immunohistochemical Study of >5800 Epithelial and Nonepithelial Tumors.PRAME 在癌症中的表达。对>5800 例上皮性和非上皮性肿瘤的系统免疫组织化学研究。
Am J Surg Pathol. 2022 Nov 1;46(11):1467-1476. doi: 10.1097/PAS.0000000000001944. Epub 2022 Aug 16.
3
Expression of cancer-testis antigens MAGEA1, MAGEA3, ACRBP, PRAME, SSX2, and CTAG2 in myxoid and round cell liposarcoma.癌胚抗原MAGEA1、MAGEA3、ACRBP、PRAME、SSX2和CTAG2在黏液样和圆形细胞脂肪肉瘤中的表达
Mod Pathol. 2014 Sep;27(9):1238-45. doi: 10.1038/modpathol.2013.244. Epub 2014 Jan 24.
4
Immunohistochemistry for PRAME in Dermatopathology.免疫组织化学染色在皮肤病理中的应用。
Am J Dermatopathol. 2023 Nov 1;45(11):733-747. doi: 10.1097/DAD.0000000000002440.
5
Cancer-testis antigen expression in synovial sarcoma: NY-ESO-1, PRAME, MAGEA4, and MAGEA1.滑膜肉瘤中癌-睾丸抗原的表达:NY-ESO-1、PRAME、MAGEA4和MAGEA1
Hum Pathol. 2017 Mar;61:130-139. doi: 10.1016/j.humpath.2016.12.006. Epub 2016 Dec 16.
6
Immunohistochemical expression of PRAME in 485 cases of epithelial tubo-ovarian tumors.PRAME 在 485 例上皮性输卵管-卵巢肿瘤中的免疫组织化学表达。
Virchows Arch. 2023 Oct;483(4):509-516. doi: 10.1007/s00428-023-03629-z. Epub 2023 Aug 23.
7
PRAME Expression in Melanocytic Tumors.黑色素细胞肿瘤中的 PRAME 表达。
Am J Surg Pathol. 2018 Nov;42(11):1456-1465. doi: 10.1097/PAS.0000000000001134.
8
The cancer/testis-antigen PRAME supports the pluripotency network and represses somatic and germ cell differentiation programs in seminomas.癌症/睾丸抗原PRAME支持多能性网络,并抑制精原细胞瘤中的体细胞和生殖细胞分化程序。
Br J Cancer. 2016 Aug 9;115(4):454-64. doi: 10.1038/bjc.2016.187. Epub 2016 Jul 21.
9
Immunohistochemical expression of PRAME is a marker of poor prognosis in uveal melanoma: A clinico-pathologic and immunohistochemical study on a series of 85 cases.PRAME 的免疫组织化学表达是葡萄膜黑色素瘤预后不良的标志物:对 85 例病例的临床病理和免疫组织化学研究。
Pathol Res Pract. 2023 Jul;247:154543. doi: 10.1016/j.prp.2023.154543. Epub 2023 May 18.
10
The prevalence of expression of MAGE-A3 and PRAME tumor antigens in East and South East Asian non-small cell lung cancer patients.MAGE-A3和PRAME肿瘤抗原在东亚和东南亚非小细胞肺癌患者中的表达率
Lung Cancer. 2016 Nov;101:137-144. doi: 10.1016/j.lungcan.2016.09.006. Epub 2016 Oct 5.

引用本文的文献

1
Blue Nevi and Melanoma Arising in Blue Nevus: A Comparative Histopathological Case Series.蓝痣及起源于蓝痣的黑色素瘤:一项组织病理学对比病例系列研究
Reports (MDPI). 2025 Aug 1;8(3):131. doi: 10.3390/reports8030131.
2
Combined immunohistochemistry of PRAME and p16 in the differentiation of melanocytic neoplasms, with a detailed focus on acral lesions.PRAME与p16联合免疫组化在黑素细胞肿瘤鉴别诊断中的应用,重点关注肢端病变
Diagn Pathol. 2024 Dec 27;19(1):167. doi: 10.1186/s13000-024-01586-y.
3
High-affinity T cell receptor ImmTAC® bispecific efficiently redirects T cells to kill tumor cells expressing the cancer-testis antigen PRAME.
高亲和力T细胞受体免疫衔接器(ImmTAC®)双特异性分子可有效重定向T细胞,以杀伤表达癌胚抗原PRAME的肿瘤细胞。
Immunother Adv. 2024 Nov 2;4(1):ltae008. doi: 10.1093/immadv/ltae008. eCollection 2024.
4
PRAME expression in melanoma is negatively regulated by TET2-mediated DNA hydroxymethylation.黑色素瘤中PRAME的表达受TET2介导的DNA羟甲基化负调控。
bioRxiv. 2024 Jul 26:2024.07.26.605293. doi: 10.1101/2024.07.26.605293.
5
Expression of Preferentially Expressed Antigen in Melanoma, a Cancer/Testis Antigen, in Carcinoma In Situ of the Urinary Tract.黑色素瘤中优先表达抗原(一种癌/睾丸抗原)在尿路原位癌中的表达
Diagnostics (Basel). 2023 Dec 10;13(24):3636. doi: 10.3390/diagnostics13243636.
6
Immunohistochemistry for PRAME in Dermatopathology.免疫组织化学染色在皮肤病理中的应用。
Am J Dermatopathol. 2023 Nov 1;45(11):733-747. doi: 10.1097/DAD.0000000000002440.
7
Immunohistochemical expression of PRAME in 485 cases of epithelial tubo-ovarian tumors.PRAME 在 485 例上皮性输卵管-卵巢肿瘤中的免疫组织化学表达。
Virchows Arch. 2023 Oct;483(4):509-516. doi: 10.1007/s00428-023-03629-z. Epub 2023 Aug 23.
8
PRAME immunohistochemistry in soft tissue tumors and mimics: a study of 350 cases highlighting its imperfect specificity but potentially useful diagnostic applications.软组织肿瘤中 PRAME 的免疫组化染色:350 例病例研究强调了其不完全的特异性,但具有潜在的有用的诊断应用。
Virchows Arch. 2023 Aug;483(2):145-156. doi: 10.1007/s00428-023-03606-6. Epub 2023 Jul 21.
9
Spatial Transcriptomic Analysis of Ovarian Cancer Precursors Reveals Reactivation of IGFBP2 during Pathogenesis.卵巢癌前体的空间转录组分析揭示了 IGFBP2 在发病机制中的重新激活。
Cancer Res. 2022 Dec 16;82(24):4528-4541. doi: 10.1158/0008-5472.CAN-22-1620.
10
POU2F3 in SCLC: Clinicopathologic and Genomic Analysis With a Focus on Its Diagnostic Utility in Neuroendocrine-Low SCLC.POU2F3 在小细胞肺癌中的表现:以其在神经内分泌低分化小细胞肺癌中的诊断效用为重点的临床病理和基因组分析。
J Thorac Oncol. 2022 Sep;17(9):1109-1121. doi: 10.1016/j.jtho.2022.06.004. Epub 2022 Jun 24.